Abstract. Subclinical hypothyroidism (SCH) is a prevalent condition among adult population, however it is frequently overlooked. Thyroid functions affect metabolic syndrome (MetS) parameters including HDL cholesterol, triglycerides, blood pressure and plasma glucose. On the other hand, the relation between MetS and thyroid dysfunction is not clearly identified yet. The aim of the present study was to investigate the prevalence of SCH among MetS patients and to identify its relation with MetS parameters. Two hundred and twenty MetS patients (MetS group; 167 female, 53 male, mean age: 48.5 ± 11.3) and 190 patients without MetS (Control group; 142 female, 48 male, mean age: 46.3 ± 11.9) attending consecutively to Internal Medicine outpatient clinics were included in this study. Groups were compared in terms of SCH prevalence. SCH was defined as a condition with high thyrotrophin and normal free thyroxine levels. SCH was found in 36 (16.4%) cases in the MetS group and in 11 (5.8%) cases in the control group (p = 0.001). Only female gender was associated with the presence of SCH. About one sixth of MetS patients had SCH. This finding indicates a need for investigating the presence of SCH during the management of MetS patients.
METABOLIC syndrome (MetS) is a cluster of risk factors and characterized by hypertension, atherogenic dyslipidemia, hyperglycemia, prothrombotic and proinflammatory conditions [1] . MetS is associated with an increased risk of atherosclerotic cardiovascular disease and type 2 diabetes [2] . Obesity, insulin resistance, physical inactivity, advanced age and hormonal imbalance have been suggested as the underlying risk factors for the development of the syndrome [3] . Epidemiological studies showed a high prevalence for MetS [4] . Subclinical hypothyroidism (SCH) is defined as an asymptomatic condition with high serum thyroid-stimulating hormone (TSH) levels and normal free thyroid hormone levels [5] . SCH has also been suggested as a risk factor for atherosclerotic cardiovascular disease, and metabolic disorders such as hyperlipidemia, hypertension, low grade inflammation and hypercoagulability may accompany this process [6] [7] [8] .
In the present study, we hypothesized that SCH may have an impact on the prevalence of MetS. With this aim, the prevalence of SCH was investigated in patients with and without MetS and the relation between SCH and MetS parameters was evaluated.
Materials and Methods
Two hundred and twenty patients with MetS and 190 controls were included in this study among consecutive patients attending the outpatient clinics of Goztepe Training and Research Hospital, Department of Internal Medicine. MetS patients required to fulfill NCEP-ATP III MetS diagnostic criteria and patients without MetS were allocated into the control group. Study protocol was approved by local ethics committee (approval date and number: 02-02-2005/20) and all patients gave written informed consent prior to study entry. The study was conducted in accordance with Declaration of Helsinki.
Patients with known diabetes or other endocrine dis-orders, patients receiving any medication that may alter thyroid functions or lipid levels, pregnant women, and patients with an abdominal mass or ascites, or severe liver, heart or renal failure were excluded. MetS and control groups were compared in terms of SCH prevalence. In addition, bivariate and multivariate analyses were done to identify any relation between SCH and MetS parameters.
A diagnosis of MetS was made if at least three of the diagnostic criteria proposed by the American National Cholesterol Education Program Adult III Treatment Panel (NCEP-ATP III) were met [blood pressure ≥130/ 85 mmHg (or use of antihypertensive medication); fasting plasma glucose ≥110 mg/dl (or use of antidiabetic medication); fasting triglycerides ≥150 mg/dl; HDL cholesterol <40 mg/dl (men) or <50 mg/dl (women); and waist circumference >102 cm (men) or >88 cm (women)] [9] .
A high serum TSH level and a normal free thyroxine (FT 4 ) level were required for the diagnosis of SCH [5] .
At baseline, demographic data was collected and a detailed physical examination was done. Sitting blood pressure was measured in both arms after at least 10 minutes of rest with an appropriate mercury sphygmomanometer using the Phase I and Phase IV Korotkoff sounds. A second measurement was made after at least 3 minutes in the arm with the highest measurement. The mean of two measurements was used for systolic and diastolic blood pressures. The waist circumference was measured at the plane between anterior superior iliac spines and lower costal margins at the narrowest part of the waistline while the patient was standing and during slight expiration. Body Mass Index (BMI) was calculated by using Quetlet index (weight/height 2 -kg/m 2 ) [10] .
Blood samples obtained following 12 hours of fasting were immediately centrifuged (2500 rpm) and the sera were separated. Glucose, total cholesterol, HDL cholesterol and triglyceride levels were determined by enzymatic methods. LDL cholesterol was determined by using Friedwald formula [11] . Serum TSH and FT 4 measurements were made with Roche Elecsys Modular Analytics E170 (Elecsys module) device by using electrochemiluminescence immunoassay "ECLIA" method. The analytical sensitivity for TSH is 0.005 µIU/ml and for FT 4 is 0.023 ng/dL. The normal range for TSH is 0.27-4.2 µIU/ml and for FT 4 is 0.93-1.7 ng/dl. Statistical analyses were made by using SPSS for Windows 10.0 software package. Inter-group comparisons of quantitative variables were made by using student t test for parameters with normal distribution and Mann Whitney U test for parameters without normal distribution. Chi-square test and Fischer's Exact Chi Square test were used for the comparison of qualitative data. A p level <0.05 considered significant and 95% confidence intervals were calculated.
Results
A total of 410 patients were included in this study. MetS group consisted of 220 patients (167 female, 53 male, mean age 48.5 ± 11.3) and control group included 190 patients (142 female, 48 male, mean age 46.3 ± 11.9). Clinical characteristics of the groups are depicted in Table 1 .
Groups were similar in terms of age, sex distribution, smoking and alcohol habits (p>0.05). None of the groups had diabetic patient. Number of patients with hypertension was 190 (86.4%) in the MetS group and 29 (15.3%) in the control group. Mean values for systolic and diastolic pressure, BMI, waist circumference, fasting plasma glucose, triglycerides, total cholesterol, LDL cholesterol, and mean number of MetS criteria were higher in the MetS group compared to controls (p<0.05). HDL cholesterol levels were lower in the MetS group compared to controls (p<0.05).
Overall, the prevalence of MetS and SCH was 53.6% (in females 40.7%, in males 12.9%) and 11.5% (in females 10%, in males 1.5%), respectively. SCH was found in 36 (16.4%) cases in the MetS group and in 11 (5.8%) cases in the control group (p = 0.001). Prevalence of SCH was higher in females with MetS compared to female controls (p = 0.0001), while it was similar in both group of male patients (p>0.05) (Fig. 1) 
Discussion
The present study found SCH in about one sixth of MetS patients. MetS is a very frequent condition in the population and our findings suggest that SCH should be investigated in at least particular group of MetS patients.
MetS is a cluster of cardiometabolic risk factors and it is characterized by inflammation [1] . It is known that cardiovascular system is very sensitive to thyroid function. Both hyperthyroidism and hypothyroidism are mostly presented by cardiovascular manifestations [12, 13] . On the other hand, a lesser degree of thyroid hormone deficiency may also affect the cardiovascular system. SCH has been found to be associated with atherosclerotic cardiovascular disease, and multiple mechanisms such as altered coagulation parameters, hyperhomocysteinemia, and low-grade chronic inflammation may accompany this process [14] [15] [16] [17] . It has been shown that C-reactive protein (CRP) value is elevated in progressive thyroid failure and metabolic syndrome [18, 19] . Tuzcu et al. [17] reported that high-sensitive C-reactive protein (hs-CRP) levels were higher in patients with SCH compared to controls. In that study, they also found a positive correlation between hs-CRP and insulin levels in both male and female SCH patients.
SCH is a frequent condition in the general population. According to National Health and Nutrition Examination Survey (NHANES III) data, SCH prevalence is 4.3% among United States population [20] . On the other hand, some series reported even higher SCH prevalence. Kvetny et al. [21] found a SCH prevalence of 19.7% among 1212 male and female cases aged between 20-69 y and without any known thyroid disease. The Rotterdam Study found 10.8% prevalence among elderly women and The Frementle Diabetes Study found a 8.6% prevalence among women with type 2 diabetes [22, 23] . In our study, we found 5.8% prevalence in the control group, in contrast we obtained a higher value for MetS patients (16.4%).
Hypothyroidism is a clinical condition leading to hy- pertension, dyslipidemia and disorders of carbohydrate metabolism. Both overt and subclinical hypothyroidism unfavorably effect biochemical parameters [24] [25] [26] . On the other hand, it has been reported that these abnormalities can be reversed by levothyroxine replacement therapy [27, 28] . Environmental and genetic factors are known to have an effect on MetS [3] . Diagnosis and management of MetS necessitates the prior identification of any other condition resulting in that particular clinical presentation and its treatment. Following questions were explored in the present study: is the presence of MetS a prompting situation to investigate SCH among patients without clinical evidence of a thyroid function disorder, and is SCH frequently observed at least in a particular group of MetS patients, a syndrome quite common among normal population. SCH was found one in every six patients with MetS, supporting our hypothesis. If long term results of thyroid replacement treatment could be demonstrated, an improvement of MetS may also be seen.
SCH is known to be more common among female gender [29] , so in the present study a higher prevalence is also expected among female patients. In addition, the increased risk found by multivariate analyses for female gender supports this relation. An association between MetS and SCH prevalence could only be demonstrated for female patients, on the other hand, number of male patients with SCH was quite low in both groups (3 male patients in MetS group and controls), which may serve as a potential cause a bias in statistical analysis. In addition to its main increasing effect on total and LDL cholesterol, SCH is also known to increase blood pressure and triglyceride levels and to decrease HDL cholesterol levels [30] . As expected, the present study found higher blood pressure, total and LDL cholesterol and triglyceride levels and lower HDL cholesterol levels among MetS patients compared to controls. However, multivariate analysis did not demonstrate an association between these parameters and SCH.
In conclusion, investigation for SCH prior to the initiation of treatment may be a reasonable strategy for MetS patients. 
